JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 8, 2004; DOI: 10.1124/jpet.104.079004


0022-3565/05/3131-24-35$20.00
JPET 313:24-35, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.079004v1
313/1/24    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peng, J.-H.
Right arrow Articles by Lukas, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peng, J.-H.
Right arrow Articles by Lukas, R. J.

NEUROPHARMACOLOGY

High-Affinity Epibatidine Binding of Functional, Human {alpha}7-Nicotinic Acetylcholine Receptors Stably and Heterologously Expressed de Novo in Human SH-EP1 Cells

Jian-Hong Peng, John D. Fryer1, Raymond S. Hurst2, Katherine M. Schroeder3, Andrew A. George4, Steven Morrissy5, Vincent E. Groppi6, Sherry S. Leonard, and Ronald J. Lukas

Division of Neurobiology, Barrow Neurological Institute, Phoenix, Arizona (J.-H.P., J.D.F., K.M.S., A.A.G., S.M., R.J.L.); Pharmacia Corporation, Kalamazoo, Michigan (R.S.H., V.E.G.); and Department of Psychiatry, University of Colorado Health Sciences Center, Denver, Colorado (S.S.L.)

Human nicotinic acetylcholine receptor (nAChR) {alpha}7 subunits were stably and heterologously expressed in native nAChR-null SH-EP1 human epithelial cells. Immunofluorescence staining shows {alpha}7 subunit protein expression in virtually every transfected cell. Microautoradiographic analysis identifies 125I-labeled {alpha}-bungarotoxin (I-Bgt) binding sites corresponding to human {alpha}7 (h{alpha}7)-nAChRs on the surface of most cells. I-Bgt binds to h{alpha}7-nAChRs in membrane fractions with a typical apparent KD value of ~5 nM and Bmax value of ~1 pmol/mg membrane protein, and 62% of these sites are expressed on the cell surface. Function of heterologously expressed h{alpha}7-nAChRs is evident as rapid, transient inward current responses to (–)-nicotine. Nicotine treatment of transfected cells produces dose- and time-dependent increases (up to ~100%) in numbers of I-Bgt binding sites. Epibatidine is a useful ligand for studies of nAChRs containing {alpha}3 or {alpha}4 subunits (KD values of about 100 or 10 pM, respectively). h{alpha}7-nAChRs expressed in transfected SH-EP1 cells also exhibit picomolar affinity binding of 3H-labeled epibatidine (KD value of ~0.6 nM). Studies of several forms of native or heterologously expressed rat or human {alpha}7-nAChRs confirm high-affinity and mutually exclusive interaction with both epibatidine and {alpha}-bungarotoxin. Rank order potencies for drugs acting to compete for binding of either radioligand are similar (methyllycaconitine > dimethylphenyl-piperazinium > nicotine ~ cytisine > carbamylcholine ~ d-tubocurarine). These results demonstrate that transfected SH-EP1 cells are excellent models for studies of heterologously expressed, human {alpha}7-nAChRs that exhibit ligand binding and functional properties like native {alpha}7-nAChRs and that epibatdine is useful as a probe for human {alpha}7-nAChRs.


Received October 7, 2004; accepted December 6, 2004.

Address correspondence to: Dr. R. J. Lukas, Division of Neurobiology, Barrow Neurological Institute, 350 West Thomas Rd., Phoenix, AZ 85013. E-mail: rlukas{at}chw.edu




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Razani-Boroujerdi, R. T. Boyd, M. I. Davila-Garcia, J. S. Nandi, N. C. Mishra, S. P. Singh, J. C. Pena-Philippides, R. Langley, and M. L. Sopori
T Cells Express {alpha}7-Nicotinic Acetylcholine Receptor Subunits That Require a Functional TCR and Leukocyte-Specific Protein Tyrosine Kinase for Nicotine-Induced Ca2+ Response
J. Immunol., September 1, 2007; 179(5): 2889 - 2898.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. Wu, Q. Liu, K. Yu, J. Hu, Y.-P. Kuo, M. Segerberg, P. A. St John, and R. J. Lukas
Roles of nicotinic acetylcholine receptor {beta} subunits in function of human {alpha}4-containing nicotinic receptors
J. Physiol., October 1, 2006; 576(1): 103 - 118.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. J. Marks, P. Whiteaker, and A. C. Collins
Deletion of the {alpha}7, beta2, or beta4 Nicotinic Receptor Subunit Genes Identifies Highly Expressed Subtypes with Relatively Low Affinity for [3H]Epibatidine
Mol. Pharmacol., September 1, 2006; 70(3): 947 - 959.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.